Cargando…
Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer
The epidermal growth factor receptor (EGFR) is overexpressed in the majority of non-small cell lung cancers (NSCLC) and is a major target for new therapies. Specific EGFR tyrosine kinase inhibitors (TKIs) have been developed and used for the treatment of advanced NSCLC. The clinical response, howeve...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2467518/ https://www.ncbi.nlm.nih.gov/pubmed/18645621 |